Viatris (VTRS) EBT Margin (2019 - 2026)
Viatris' (VTRS) quarterly EBT Margin came in at 7.05% in Q1 2026, up 8812.0% year-on-year from 0.08% in Q1 2025, and up 23.17% quarter-over-quarter from 9.17% in Q4 2025.
Viatris (VTRS) EBT Margin (2019 - 2026) Analysis & Trends
Viatris' EBT Margin history runs 8 years deep, the most recent figure standing at 7.05% for Q1 2026.
- On a quarterly basis, EBT Margin rose 8812.0% year-over-year to 7.05% in Q1 2026; TTM through Mar 2026 was 5.59%, a 2191.0% increase from a year earlier, with the FY2025 full-year figure at 25.63%, down 2139.0% from the prior year.
- EBT Margin grew to 7.05% in Q1 2026 per VTRS's latest filing, from 9.17% in the prior quarter.
- Across five years, EBT Margin topped out at 37.55% in Q4 2022 and bottomed at 95.17% in Q1 2025.
- The 5-year median for EBT Margin is 2.41% (2024), against an average of 3.54%.
- Across the five-year window, EBT Margin tumbled 10075 bps in 2025 and surged 8812 bps in 2026, its largest moves.
- Year by year, EBT Margin stood at 37.55% in 2022, then sank by 160 bps to 22.51% in 2023, then surged by 33 bps to 15.12% in 2024, then soared by 39 bps to 9.17% in 2025, then increased by 23 bps to 7.05% in 2026.
- Per Business Quant, the three latest VTRS EBT Margin figures stand at 7.05% (Q1 2026), 9.17% (Q4 2025), and 0.21% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 10.97% |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 33.51% |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -41.57% |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 40.73% |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -7.05% |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 30.30% |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 6.35% |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | -3.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.05% |
| Dec 31, 2025 | -9.17% |
| Sep 30, 2025 | -0.21% |
| Jun 30, 2025 | -6.08% |
| Mar 31, 2025 | -95.17% |
| Dec 31, 2024 | -15.12% |
| Sep 30, 2024 | 2.41% |
| Jun 30, 2024 | -10.35% |
| Mar 31, 2024 | 5.58% |
| Dec 31, 2023 | -22.51% |
| Sep 30, 2023 | 10.22% |
| Jun 30, 2023 | 8.50% |
| Mar 31, 2023 | 8.65% |
| Dec 31, 2022 | 37.55% |
| Sep 30, 2022 | 10.51% |
| Jun 30, 2022 | 9.48% |
| Mar 31, 2022 | 12.63% |
| Dec 31, 2021 | -4.63% |
| Sep 30, 2021 | 4.42% |
| Jun 30, 2021 | -4.80% |